Table 4.

Logistic regression of association between demographic and clinical factors of 77 patients with depression and the effectiveness (≥50% reduction in baseline HAMD-17 total score) and remission (final HAMD-17 under 7) of 12 weeks of treatment with duloxetine^a

variables	effectively treated		remission
	odds ratio (95% confidence interval)		odds ratio (95% confidence interval)
Family history of affective disorders	1.03 (0.31-3.42)		1.28 (0.44-3.71)
baseline HAMD-17 value	1.03 (0.88-1.20)		0.87 (0.75-1.00)
age	3.86 (0.29-51.00)		1.74 (0.32-9.56)
female gender	1.67 (0.54-5.21)		0.97 (0.35-2.65)
unmarried	1.05 (0.18-6.13)		1.42 (0.31-6.52)
age of onset	0.26 (0.20-3.44)		0.59 (0.11-3.27)
total duration of illness	0.89 (0.72-1.11)		0.95 (0.83-1.10)
number of episodes	1.03 (0.54-2.00)		1.22 (0.69-2.15)

HAMD-17, 17-item version of the Hamilton Depression rating scale

^a during the 12 weeks of treatment, 77% (59/77) of the patients were effectively treated and 55.8% (43/77) remitted